Healthcare -
Biotechnology - NYSE - US
$ 7.58
-4.37 %
$ 444 M
Market Cap
-0.81
P/E
DNA - OPERATING INCOME
Operating Income DNA - Ginkgo Bioworks Holdings, Inc.
-560 M
LAST VALUE
49.66%
2 YEAR CAGR
-50.88%
5 YEAR CAGR
0.00%
10 YEAR CAGR